CLINICAL ROLE -
Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors
Eli Lilly and Company (NYSE: LLY) and AstraZeneca (NYSE: AZN) today announced that they have entered into a clinical trial collaboration to evaluate safety and preliminary efficacy of their products.
Amgen Launches Program To Further Advance Basic Biology Research
Amgen today announced the creation of a catalog of qualified tools and reagents available to academic institutions to help further research and advance basic discoveries in biology.
Johnson & Johnson Announces Acceptance of Binding Offer From Cardinal Health To Acquire Cordis
Johnson & Johnson (NYSE: JNJ) today announced the acceptance of the March 1, 2015 binding offer from Cardinal Health to acquire its Cordis business for an approximate value of $2 billion.
Cardinal Health Specialty Solutions: New Studies Reinforce Important Role Real-World Patient Data Can Play in Developing Value-based Reimbursement Strategies
Later this week, Cardinal Health Specialty Solutions will present a new series of health economic outcomes research (HEOR) studies.
Infectious Disease Experts, Scientists and Clinicians Join Forces on SHARE IDâ„¢ to Accelerate the Battle Against Antibiotic-resistant Infections
Initiative supported by Actavis aims to help advance evidence-based treatment practices using unique data-sharing platform.
AbbVie Completes Acquisition of Pharmacyclics
AbbVie (NYSE: ABBV), a global biopharmaceutical company, announced today that it has completed the acquisition of Pharmacyclics, Inc.
Mylan N.V. today announced that it was asked by the Irish Takeover Panel to issue the following clarification and retraction in accordance with the Irish Takeover Rules (the "Rules").
2 Clarke Drive Cranbury, NJ 08512